Literature DB >> 11072185

Optimizing target coverage by dosimetric feedback during prostate brachytherapy.

R A Cormack1, C M Tempany, A V D'Amico.   

Abstract

PURPOSE: Postimplant dosimetry of permanent prostate implants shows a loss of coverage compared to the preplan. One contributing factor is needle misplacement. The significance of needle misplacement and the clinical utility of dosimetric feedback were analyzed in the setting of interventional magnetic resonance (IMR) guided prostate brachytherapy. METHODS AND MATERIALS: Information provided by an intraoperative planning system was analyzed for 10 patients. Needle misplacement was measured and the dosimetric consequences calculated. Additional catheters and sources were placed following the insertion of all planned catheters to compensate for nonideal needle placement.
RESULTS: Source misplacement ranged from 0.0 to 1.0 cm (median, 0.3 cm). The resulting loss of coverage ranged from 1% to 13%, and the intraoperative dosimetric feedback allowed a recovery of from 0% to 12% coverage. Between 0 and 3 (median, 2) additional needles and from 0 to 10 (median, 8) additional sources were required to restore coverage of the target. Final planned coverage exceeded 94% for all patients.
CONCLUSION: The discrepancy between planned and achieved needle placement leads to a loss of dosimetric coverage of the target volume. Dosimetric feedback allows compensation for needle divergence. The technique of real-time dosimetric feedback does not require an IMR system, and could be generalized to ultrasound-guided implants.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072185     DOI: 10.1016/s0360-3016(00)00742-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Magnetic resonance imaging compatible robotic system for fully automated brachytherapy seed placement.

Authors:  Michael Muntener; Alexandru Patriciu; Doru Petrisor; Dumitru Mazilu; Herman Bagga; Louis Kavoussi; Kevin Cleary; Dan Stoianovici
Journal:  Urology       Date:  2006-12       Impact factor: 2.649

2.  Clinical use of magnetic resonance imaging across the prostate brachytherapy workflow.

Authors:  P Blanchard; C Ménard; S J Frank
Journal:  Brachytherapy       Date:  2017-01-30       Impact factor: 2.362

3.  AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.

Authors:  Ravinder Nath; William S Bice; Wayne M Butler; Zhe Chen; Ali S Meigooni; Vrinda Narayana; Mark J Rivard; Yan Yu
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

4.  3-T MR-guided brachytherapy for gynecologic malignancies.

Authors:  Tina Kapur; Jan Egger; Antonio Damato; Ehud J Schmidt; Akila N Viswanathan
Journal:  Magn Reson Imaging       Date:  2012-08-13       Impact factor: 2.546

Review 5.  Feasibility of functional imaging for brachytherapy.

Authors:  Alfredo Polo
Journal:  J Contemp Brachytherapy       Date:  2009-03-23

Review 6.  Image fusion techniques in permanent seed implantation.

Authors:  Alfredo Polo
Journal:  J Contemp Brachytherapy       Date:  2010-10-13

7.  Axially rigid steerable needle with compliant active tip control.

Authors:  M de Vries; J Sikorski; S Misra; J J van den Dobbelsteen
Journal:  PLoS One       Date:  2021-12-16       Impact factor: 3.240

8.  Clinical application and accuracy assessment of imaging-based surgical navigation guided 125I interstitial brachytherapy in deep head and neck regions.

Authors:  Guohao Zhang; Zhiyuan Wu; Wenting Yu; Xiaoming Lyu; Wenjie Wu; Yi Fan; Yong Wang; Lei Zheng; Mingwei Huang; Yi Zhang; Chuanbin Guo; Jianguo Zhang
Journal:  J Radiat Res       Date:  2022-09-21       Impact factor: 2.438

9.  Assessment of I-125 seed implant accuracy when using the live-planning technique for low dose rate prostate brachytherapy.

Authors:  Joshua Moorrees; John M Lawson; Loredana G Marcu
Journal:  Radiat Oncol       Date:  2012-11-22       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.